Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Recruiting Observational Study
Lung Transplant Rejection
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
700 (estimated)
Sponsor
University of Alberta · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All lung transplant recipients undergoing a biopsy as determined by their surgeon or physician. Exclusion Criteria: * Patients who declined participation or unable to give informed consent.
Contacts

Konrad S Famulski, PhD

1 780 492 1725

konrad@ualberta.ca

CONTACT

Robert Polakowski, PhD

1 780 492 5091

polakows@ualberta.ca

CONTACT